These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7944409

  • 1. Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
    Takahashi N, Breitman TR.
    Arch Biochem Biophys; 1994 Oct; 314(1):82-9. PubMed ID: 7944409
    [Abstract] [Full Text] [Related]

  • 2. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
    Taimi M, Breitman TR.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):432-6. PubMed ID: 9125196
    [Abstract] [Full Text] [Related]

  • 3. Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.
    Hashimoto Y, Kagechika H, Kawachi E, Shudo K.
    Jpn J Cancer Res; 1988 Apr 17; 79(4):473-83. PubMed ID: 2838445
    [Abstract] [Full Text] [Related]

  • 4. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N, Sausville EA, Breitman TR.
    Clin Cancer Res; 1995 Jun 17; 1(6):637-42. PubMed ID: 9816026
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H, Dawson MI, Hong WK, Lotan R.
    Oncogene; 1997 Oct 23; 15(17):2109-18. PubMed ID: 9366527
    [Abstract] [Full Text] [Related]

  • 9. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ, Vollberg TM, Nervi C, Grippo JF, Dawson MI, Jetten AM.
    Cell Growth Differ; 1996 Mar 23; 7(3):327-37. PubMed ID: 8838863
    [Abstract] [Full Text] [Related]

  • 10. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR, He RY.
    Cancer Res; 1990 Oct 01; 50(19):6268-73. PubMed ID: 2400989
    [Abstract] [Full Text] [Related]

  • 11. Potential applications of cytodifferentiation therapy in hematologic malignancies.
    Breitman TR, Chen ZX, Takahashi N.
    Semin Hematol; 1994 Oct 01; 31(4 Suppl 5):18-25. PubMed ID: 7831581
    [Abstract] [Full Text] [Related]

  • 12. Tunicamycin in combination with retinoic acid synergistically inhibits cell growth while decreasing palmitoylation and enhancing retinoylation of proteins in the human breast cancer cell line MCF-7.
    Takahashi N, Iwahori A, Breitman TR, Fukui T.
    Oncol Res; 1997 Oct 01; 9(10):527-33. PubMed ID: 9507530
    [Abstract] [Full Text] [Related]

  • 13. Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's).
    Hashimoto Y, Kagechika H, Shudo K.
    Biochem Biophys Res Commun; 1990 Feb 14; 166(3):1300-7. PubMed ID: 2154975
    [Abstract] [Full Text] [Related]

  • 14. Proteins in human myeloid leukemia cell line HL60 reacting with retinoic acid monoclonal antibodies.
    Kubo Y, Ohba T, Takahashi N.
    J Biochem; 2008 Sep 14; 144(3):349-55. PubMed ID: 18511450
    [Abstract] [Full Text] [Related]

  • 15. Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo.
    Ohyanagi N, Ishido M, Suzuki F, Kaneko K, Kubota T, Miyasaka N, Nanki T.
    Arthritis Rheum; 2009 Oct 14; 60(10):3118-27. PubMed ID: 19790078
    [Abstract] [Full Text] [Related]

  • 16. Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis.
    Bunce CM, Wallington LA, Harrison P, Williams GR, Brown G.
    Leukemia; 1995 Mar 14; 9(3):410-8. PubMed ID: 7885039
    [Abstract] [Full Text] [Related]

  • 17. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.
    Umemiya H, Fukasawa H, Ebisawa M, Eyrolles L, Kawachi E, Eisenmann G, Gronemeyer H, Hashimoto Y, Shudo K, Kagechika H.
    J Med Chem; 1997 Dec 19; 40(26):4222-34. PubMed ID: 9435893
    [Abstract] [Full Text] [Related]

  • 18. Action mechanism of retinoid-synergistic dibenzodiazepines.
    Umemiya H, Kagechika H, Fukasawa H, Kawachi E, Ebisawa M, Hashimoto Y, Eisenmann G, Erb C, Pornon A, Chambon P, Gronemeyer H, Shudo K.
    Biochem Biophys Res Commun; 1997 Apr 07; 233(1):121-5. PubMed ID: 9144408
    [Abstract] [Full Text] [Related]

  • 19. [Induction differentiation by a new third generation retinoid R9158 on human acute promyelocytic leukemia cell line, NB4].
    He X, Han R.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Dec 07; 20(6):459-65. PubMed ID: 11717940
    [Abstract] [Full Text] [Related]

  • 20. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.